- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02375750
Treatment of Peri-implantitis Lesions by Using Biomaterial
Surgical Treatment of Peri-implantitis Lesions, With or Without the Placement of a Bone Substitute and a Collagen Membrane. A Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patient who will considered eligible at the screening visit will undergo surgical treatment procedure within 2 weeks. At the day of the surgery the patients will be randomized into the 2 treatment groups.
The subjects will be then prescribed postoperative antibiotics (Azitromax 500 mg day one and 250 mg day 2-4).
Post-operative pain will be controlled with Ibuprofen (400mg x 3) for two days to all subjects. Subjects will rinse twice daily with Chlorhexidine mouth rinse and use modified oral hygiene procedures during the first 5 weeks of healing. Subjects will receive professional prophylaxis as required.
Subjects will be instructed on appropriate oral hygiene throughout the study and will be given appropriate oral hygiene instructions. Instructions on post-operative care will be repeated at each visit. In particular the following points have to be covered during the first month after surgery: Chlorhexidine rinses, avoidance of brushing, usage of interdental cleaning devices, avoidance of chewing on or trauma to the treated area. In addition subjects will be instructed not to smoke more than 10 cigarettes per day during the entire study period and not to consume alcohol during antibiotic therapy.
Sutures will be removed after 14 days. Photos will be taken during the whole study to document the healing process.
Further follow up visits will be scheduled 6 weeks and 3,6,9,12 months post-surgery.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kristianstad, Sweden, 29188
- Kristianstad University, Department of Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- age 18 years or older
- Presence of peri-implantitis
- A peri-implant intraosseous defect with at least 3 mm defect depth as seen on an intraoral radiograph.
- Clinically a probing depth ≥ 5 mm combined with bleeding and/or pus should be present at the site.
- During surgical exploration an intraosseous component of at least 3 mm at the deepest point must be present.
- The defect should have a minimum of 3 osseous walls (a circumference of the osseous defect of at least 270 degrees). Only 3 and 4 wall intraosseous defects will be included.
- Implants included in the study must have been in function for more than 12 months.
- Ability to fully understand the nature of the proposed surgery and ability to sign an Ethics Committee-approved informed consent form
Exclusion Criteria:
- Subjects with diabetes mellitus (HbA1c > 7.0)
- Subjects taking prednisone or other anti-inflammatory prescription drug
- Subjects taking medications known to have effects on gingival growth
- If the same patient has more than one defect meeting the inclusion criteria, only one such defect will be included in the study
- General contraindications for dental and/or surgical treatments
- Smokers (> 10 cigarettes per day).
- Pregnant or lactating women
- Allergy to collagen
- Inability to consent for participation in the study and/or to accept the proposed
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: GBO and GBG
0.2 g-0,5 g GBO and 1 GBG once after decontamination of implant surface
|
Application of GBO and GBG to the defect fill after removal of chronic inflammatory tissue and decontamination of the surface of implant
|
Active Comparator: Standard treatment
Decontamination of surface of implant
|
Removal of chronic inflammatory tissue using titanium curettes and a rotary titanium brush; Implant Surface decontamination and closure by suturing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in the dimensions of the bone defect
Time Frame: 6 months, 1 year
|
6 months, 1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in pocket depth
Time Frame: 3 months,6months, 9 months,12months
|
3 months,6months, 9 months,12months
|
Change in gingival inflammation
Time Frame: 3 months,6months, 9 months,12months
|
3 months,6months, 9 months,12months
|
Changes in recession of the mucosal margin
Time Frame: 3 months,6months, 9 months,12months
|
3 months,6months, 9 months,12months
|
Subject satisfaction with the outcome at the study end
Time Frame: 12months
|
12months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stefan Renvert, Professor, Department of Health Sciences, Kristianstad University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GS13530231
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peri-implantitis
-
PolyPid Ltd.MIS Implant Technologies, LtdCompleted
-
University of ManitobaUnknownPeri ImplantitisCanada
-
University of ValenciaCompletedEarly Apical Peri-implantitis
-
Rambam Health Care CampusRecruitingDental Implants,Peri-implantitis,SmokingIsrael
-
Tuğba ŞAHİNCompletedPeri-Implantitis, Peri-implant MucositisTurkey
-
Proed, Torino, ItalyCompleted
-
University of ZagrebNot yet recruitingPeri-implant Mucositis | Peri-Implantitis and Peri-implant Mucositis | Peri-implant Health | Periimplant Diseases | Periimplant Bone Loss
-
National and Kapodistrian University of AthensRecruitingPeri-Implantitis | Peri-Implant HealthGreece
-
Center of Implantology, Oral and Maxillofacial...Recruiting
-
University of BaghdadRecruiting
Clinical Trials on GBO and GBG
-
West German Center of Diabetes and Healthgbo Medizintechnik AGCompleted
-
West German Center of Diabetes and Healthgbo Medizintechnik AGCompletedChronic Radicular Back Pain | Lumboischialgia | Cervico BrachialgiaGermany
-
Paracelsus Medical UniversitySalzburger LandesklinikenCompletedPeripheral Nervous System ProblemAustria
-
Shenzhen Geno-Immune Medical InstituteUnknown
-
University Hospitals Cleveland Medical CenterUnknownAsthma | Allergic Rhinitis | Allergic ConjunctivitisUnited States
-
Rutgers, The State University of New JerseyNational Institute on Drug Abuse (NIDA); University of UtahRecruitingTobacco Use | Opioid Use | Polysubstance AbuseUnited States
-
University of North Carolina, Chapel HillCompletedIntestinal Volvulus | Colon, SigmoidMalawi
-
University of JohannesburgCompletedOsteoarthritisSouth Africa
-
Wayne State UniversityUniversity of Michigan; St. John Providence HospitalCompleted
-
University of GlasgowCompleted